GALDERMA LABORATORIES, INC. – Trademark Portfolio
Entity Type: 03
GALDERMA LABORATORIES, INC. holds 20 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 15 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 2 trademarks are registered and 1 is pending. Notable registered marks include ORACEA and BENZAC AC. The owner is based in FORT WORTH, TX.
SUITE 300
3000 ALTA MESA BOULEVARD
FORT WORTH, TX 76133
Showing of trademarks Trademarks
Trademark Classifications
GALDERMA LABORATORIES, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does GALDERMA LABORATORIES, INC. have?
GALDERMA LABORATORIES, INC. has 20 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 pending, 2 abandoned, 15 cancelled.
What trademark classes does GALDERMA LABORATORIES, INC. file in?
GALDERMA LABORATORIES, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are GALDERMA LABORATORIES, INC.'s most well-known trademarks?
GALDERMA LABORATORIES, INC.'s registered trademark portfolio includes well-known marks such as ORACEA and BENZAC AC. These are among 2 currently registered trademarks in the portfolio.
What is GALDERMA LABORATORIES, INC.'s trademark registration success rate?
GALDERMA LABORATORIES, INC. has a 11% trademark registration rate, with 2 out of 19 resolved applications resulting in successful registration. Currently, 1 application is pending review.